There may be significant potential in a long-acting oral antimalarial. This drug could have consequences for mass drug administration strategies, as well as eventual malaria elimination targets.

Author: Barman R, Bellinger AM, Bensel T, Booth L, Cleveland C, Daily J, Eckhoff PA, Grant TM, Hurowitz HM, Jafari M, Kogan L, Langer R, Lee YL, Mazdiyasni H, Minahan D, Mo S, Nikolic B, Slater HC, Tai T, Traverso G, Wenger EA, Wood L, Zhang S
Publication date: November 2016
Source: Science Translational Medicine